AstraZeneca, Plaintiffs to Argue FDA Bill's Effect on Preemption



DOCUMENTS
  • Motions


ORLANDO, Fla. - A recent FDA reform bill signed into law by President George W. Bush will be the focus of the latest round of briefing in the battle over whether Seroquel personal injury claims are preempted by the Food, Drug & Cosmetic Act. In Re: Seroquel Products Liability Litigation, MDL No. 1769 (M.D. Fla.).

The Florida U.S. District Court overseeing MDL proceedings for claims related to the atypical antipsychotic recently granted motions by plaintiffs and defendant AstraZeneca to allow for supplemental briefing on what impact, if any, the new law may have on the preemption argument.

H.R. 3580, the …






UPCOMING CONFERENCES




HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS



HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024 - Salt Lake City, UT
The Grand America Hotel

MORE DETAILS